• The 7th annual UK E-Cigarette Summit will take place on Thursday 14th November 2019 at The Royal Society, London

Science, regulation and public health

Smoking is the biggest single cause of preventable death in the developed world with almost 1 billion users worldwide. The devastating effect of long-term smoking cannot be underestimated, with approximately half of all lifetime smokers dying from smoking related diseases and many more suffering a compromised quality of life.  Despite decades of tobacco control efforts and public health education on the harms of smoking, the decline in smoking rates has been frustratingly slow.

The growth of e-cigarette over the last 6-7 years can best be viewed as an unfolding phenomenon.  The public health response has ranged from enthusiastic support to vigorous opposition as scientists and regulators grapple to find the most appropriate response.  Their verdicts will probably feature among the key public health decisions of our time.

The much anticipated NASEM report published earlier this year, supported the PHE and Royal College of Physicians findings that e-cigarettes posed a fraction of the risk to combustible tobacco. The report highlighted that the public health impact of e-cigarettes will depend on the balance of 3 factors i) The ability to help current smokers quit ii) The potential to increase adolescents’ use of combustible cigarettes iii) Any inherent toxicity of e-cigarettes themselves.

The E-Cigarette Summit provides a much needed neutral platform to explore the available peer reviewed evidence and debate the issues that are dividing scientists, health professionals and policy makers alike. So, are-cigarettes a valuable harm reduction strategy or a tacit U-turn on decades of effective tobacco control efforts? Whichever side of the debate you fall on, this is likely to be one of the most significant public health issues for a generation.

Key Topics:

  • Communicating risks and benefits – are we getting the regulatory policies right?
  • What can we learn from the Scandinavian experience about the impact of tobacco harm reduction
  •  E-cigarettes and history, why countries have different policies yet share the same evidence
  • How to manage unanswered questions in tobacco harm reduction research
  • Why are LMIC countries typically favouring restrictive policies toward e-cigarettes
  • Does the” JUUL Phenomenon” change the public health calculations for e-cigarettes
  • Why is the US reporting a surge in youth use which has not been seen in the UK
  • Disentangling the gateway hypothesis using a variety of methodological and analytical approaches
  • Do e-cigarettes help smokers to quit and should clinicians recommend e-cigarettes to all smokers
  • Flavours and why they are important to consumers and public health
  • Harm reduction for all – how do we reach those most in need but hardest to work with
  • Understanding the different product categories
  • Flavours and why they are important to consumers and public health

2018 Speakers Include:

  • (Chair) Prof Ann McNeill, Professor of Tobacco Addiction, UK Centre for Tobacco and Alcohol Studies, Kings College London
  • Prof Virginia Berridge, Professor of History, London School of Hygiene and Tropical Medicine, Senior Editor History, Addiction Journal
  • Judith Watt, International Tobacco Control Consultant
  • Deborah Arnott, Chief Executive, Action on Smoking and Health
  • Dr Karl E. Lund, Research Director of the Tobacco Unit at the Norwegian Institute for Drug and Alcohol Research
  • James Van Loon, Director General, Tobacco Control Directorate, Health Canada
  • Prof Nancy Rigotti, Director Tobacco Research & Treatment Center, Massachusetts General Hospital, Boston
  • Prof Linda Bauld, Professor of Public Health, University of Edinburgh
  • Dr Konstantinos Farsalinos, Research Fellow, Onassis Cardiac Surgery Greece
  • Prof Robert West, Professor of Health Psychology & Director of Tobacco Studies
  • Prof Peter Hajek, Professor of Clinical Psychology, Wolfson Institute of Preventive Medicine, Queen Mary University of London
  • Dr Lion Shahab, Senior Lecturer in Health Psychology, University College London
  • Rt Hon Norman Lamb, MP, Chair of the House of Commons Science and Technology Committee
  • Ben Youdan, ASH New Zealand
  • Oliver Kershaw, Founder of the E-Cigarette Forum and
  • Victoria Foy, COO, Flavour Warehouse and IBVTA Board Member
  • Tim Phillips, Managing Director, ECigIntelligence
  • Martin Dockrell, Tobacco Control Programme Lead, Public Health England
  • Tim Marczylo, Principal Toxicologist, Public Health England
  • Kuiama Thompson, Specialty Registrar in Public Health, Rochdale Borough Council
  • Dr Frances Thirlway, Research Fellow, University of York
  • (Closing Address) Dr Sharon Cox, Research Fellow, London South Bank University’s Centre for Addictive Behaviours Research

To see speaker biographies please click here